A recent study suggests that people who stop using new weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds much more quickly than those who halt conventional diet and exercise regimens.
Findings released in a prominent health publication demonstrates that while overweight people can lose substantial amounts of their total mass while using the jabs, the mass returns at an estimated rate of 0.8 kg per month upon discontinuation.
"People purchasing these drugs need to be cognizant of the potential of quick weight regain when the medication concludes," cautioned expert Dr. Susan Jebb.
Such speed of regain implies a reversion to starting weight in about a year and a half.
Analyzing Treatments
The study, which examined 37 of studies involving thousands of patients, compared the outcomes of the injectable medications with other pills.
The team point out that people who shed pounds through lifestyle changes alone usually see a slower weight regain—perhaps 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Doctors propose the mechanism of the jabs explains the heightened weight return.
The injections copy a natural hormone called GLP-1, which controls appetite.
"Sustained high doses of the hormone concentrations far above than the body's typical production may cause the system to produce less of its endogenous hormone, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a nutrition expert.
"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making excessive eating a significant risk."
A Chronic Condition?
Medical guidelines recommend the jabs for individuals with weight-linked health risks, accompanied by prescribed lifestyle changes.
A number of clinicians argue that, given the high risk of weight regain, the treatment should be considered life-long.
This view is supported by pharmaceutical companies, who note that the results "emphasize the chronic nature of excess weight," comparing it to managing conditions like hypertension.
Patient Experiences
Individuals who have discontinued the jabs report a sudden resurgence of appetite.
"It felt as if a switch that goes on and I was suddenly ravenous," recalled a patient.
The struggle is compounded if patients have not developed sustainable dietary or behavioural changes during treatment.
Widespread Use
Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.
- Use is more common among women than men.
- The middle-aged demographic shows the highest level of interest.
- A large proportion access the drugs through private healthcare rather than the NHS.
In conclusion, clinicians emphasize that while the jabs are potent agents for shedding pounds, they are not a standalone cure and long-term success relies on integrated behavioural support.